November 29, 2016 - By Peter Kolinski
finnCap currently has a GBX 28.00 TP on the 20.23M GBP market cap company or 51.35% upside potential. In a research report published on 29 November, Omega Diagnostics Group PLC (LON:ODX) stock had its “Corporate” Rating restate by stock research analysts at finnCap.
About 38,629 shares traded hands. Omega Diagnostics Group Plc (LON:ODX) has risen 16.54% since April 29, 2016 and is uptrending. It has outperformed by 11.28% the S&P500.
Omega Diagnostics Group PLC is a medical diagnostics company. The company has a market cap of 20.23 million GBP. The Company’s divisions are Allergy and Autoimmune; Food Intolerance; Infectious/Other, and Corporate. It has a 30.88 P/E ratio. The Company’s product categories include allergy, anemia, autoimmunity, fertility and growth hormones, food intolerance, infectious disease, inflammation, quality control, thyroid hormones and tumor markers.
Another recent and important Omega Diagnostics Group Plc (LON:ODX) news was published by Fool.Co.Uk which published an article titled: “Should I Sell Shire plc & Buy Omega Diagnostics Group plc Right Now?” on July 07, 2015.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.